WELL reported record quarterly revenues of $99.3 million in Q3-2021 reflecting a 711% year-over-year (YoY) increase compared to Q3-2020. WELL's...
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 10, 2021 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the world's most trusted solution to power...
BOSTON, Nov. 10, 2021 /PRNewswire/ -- Donald Rucker, MD, former National Coordinator for Health Information Technology (ONC) in the United States...
KYOTO, Japan, Nov. 10, 2021 /PRNewswire/ -- OMRON Corporation based in Kyoto, Japan, has announced the development of a new...
NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the...
NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for...
GRAZ, Austria, Nov. 10, 2021 /PRNewswire-PRWeb/ -- eMurmur®, a technology partner to the global healthcare community, announces the world's first open...
State-of-the-art centre to focus on digital and robotic surgery LONDON, Nov. 9, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global...
Denver, Colorado--(Newsfile Corp. - November 10, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp...
Continuous monitoring device with advanced features and analytics to deliver personalized insights directly to the smartphone REDWOOD CITY, Calif.--(BUSINESS WIRE)--Biotricity,...
New AI tool helps proactively screen, test and identify people at risk for COVID FAIRFAX, Va.--(BUSINESS WIRE)--Vibrent Health, a...
LOS ANGELES, Nov. 10, 2021 /PRNewswire/ -- Building on the success of the Optimal Wellbeing Program (OWP) that launched in...
Ovid is implementing its business development program which intends to secure a series of opportunities that complement and enhance its...
ACTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company...
RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks, proceeding; topline data reaffirmed for 2022CHAPTER-1, Phase...
Live moderated video webcast discussion among members of management and Thought Leaders Firas M. Rahhal, MD and Robert L. Avery,...
WESTLAKE VILLAGE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing...
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET LYON, France, November 10, 2021...
John Maraganore, Ph.D., Mark McClellan, M.D., Ph.D. and Andrew Lo, Ph.D. appointed as Executive Advisors to support SalioGen’s efforts to...
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...